Experts in Molecular Anatomic Pathology Services
Geneuity Clinical Research Services has a decade of experience in biomarker assay testing. Our expertise in specialty testing, innovative solutions and technologies, ensures Geneuity is the best choice to meet your clinical study testing needs.
Geneuity is a provider of outsourced specialty laboratory testing services for drug discovery and companion diagnostics addressing the needs of small pharma, biotechnology, contract research organizations, and medical device companies. Geneuity can seamlessly integrate with your development team by providing personalized services for studies of a few samples to those involving thousands of specimens on a global scale.
Diagnostic experience and medical device validation
Experience in molecular diagnostics as a clinical reference laboratory for more than two decades brings expertise to conducting medical diagnostic validation testing. Access to sample types, bioinformatics, and pathology consultation ensures timely results and shorter time to regulatory submission.
Therapeutic experience and clinical trial testing
Partnering with a leader in genomic medicine with more than 10 years in research services brings expert knowledge and application in molecular diagnostic assay development, clinical testing, and bioinformatics.
Geneuity delivers timely results for an expedient regulatory submission ensuring minimal trial cost and better outcomes.
Molecular Anatomic Pathology
Conducting assays in anatomic pathology and hematopathology oncology we can provide:
- Quantitative PCR
- Gene sequencing
- 5 to 10 color flow cytometry
- Metaphase and Interphase cytogenetics
- Fluorescence in situ hybridization
- Immunohistochemistry and special stains
- Chromogenic in situ hybridization
- Biomarker consult
Contact our clinical affairs office to request a consultation for your next validation study.
ROGER A. HUBBARD, PHD
FOUNDER, PRESIDENT, CHIEF EXECUTIVE OFFICER
Dr. Roger Hubbard provides scientific and executive leadership to Geneuity and its parent company, Molecular Pathology Laboratory Network, Inc. (MPLN).
In 1989, Dr. Hubbard founded MPLN after completing doctoral studies in biochemistry and molecular biology at the Medical University of South Carolina in Charleston and subsequent training in the Department of Microbiology and Immunology at the University of Arizona Health Sciences Center in Tucson. He holds the academic rank of adjunct associate professor in the Department of Pathology at the University of Tennessee Medical Center in Knoxville, and holds the high-complexity Clinical Laboratory Director certification from the American Board of Bioanalysis.
Dr. Hubbard is a laboratory inspector within the Laboratory Accreditation Program of the College of American Pathologists. He is a clinical scientist member of the American Society of Clinical Pathologists and a charter member of the Clinical Cytometry Society. Dr. Hubbard has written numerous publications in the areas of clinical flow cytometry, molecular immunology, infectious disease diagnostic testing, and molecular oncology.
PAUL TRAVIS BSC MSC
BUSINESS DEVELOPMENT – VICE PRESIDENT
VICE PRESIDENT, BUSINESS DEVELOPMENT
25 years of experience in Pharma & Contract research. Specialist Biomarker labs, global central labs & phase I-IV clinical research
Mark Stonecypher, MD, PhD
Chief Medical Officer
Anatomic and Clinical Pathology, Fellowship trained in Anatomic Pathology, Fellowship trained in Hematopathology